Amitriptyline is NOT an SSRI and Should Not Be Used as One
Amitriptyline is a tricyclic antidepressant (TCA), not a selective serotonin reuptake inhibitor (SSRI), and these are fundamentally different drug classes with distinct mechanisms of action. While amitriptyline does inhibit serotonin reuptake, it also blocks norepinephrine reuptake, muscarinic receptors, histamine receptors, and ion channels—making it pharmacologically distinct from SSRIs 1.
Critical Drug Interaction Warning
Combining amitriptyline with SSRIs requires extreme caution due to significant drug-drug interactions. SSRIs (fluoxetine, sertraline, paroxetine) inhibit cytochrome P450 2D6, which metabolizes amitriptyline. This can cause up to an 8-fold increase in amitriptyline plasma concentrations, leading to potentially dangerous toxicity 1. When switching from an SSRI to amitriptyline, sufficient time must elapse—particularly with fluoxetine, which requires at least 5 weeks due to its long half-life 1.
For Tension-Type Headache Treatment
In your patient with three days of retro-orbital pressure and band-like tension-type headache:
Acute Treatment (First 3 Days)
- Start with ibuprofen 400 mg or acetaminophen 1000 mg for acute symptom relief 2
- These are first-line for episodic tension-type headache
- Avoid frequent use (>2 days/week) to prevent medication-overuse headache
If Headaches Become Chronic (≥15 days/month for 3+ months)
Amitriptyline 30-150 mg/day is the first-line prophylactic agent for chronic tension-type headache 3. This recommendation is based on consistent evidence showing:
- 30% reduction in headache burden compared to placebo 4
- Reduces headache duration, frequency, and analgesic intake 4
- Most effective at doses of 30-150 mg/day, though real-world practice shows many patients respond to lower doses (10-25 mg/day) 5
Start at 10 mg nightly and titrate slowly based on response and tolerability 5. Common side effects include drowsiness, weight gain, and anticholinergic symptoms (dry mouth, constipation) 1.
Why SSRIs Are NOT Appropriate
SSRIs have no proven efficacy for tension-type headache prevention. A Cochrane review found that SSRIs (including citalopram, sertraline, fluoxetine, paroxetine) showed no difference from placebo in reducing headache frequency 6. Direct comparison studies demonstrate that:
- Citalopram (an SSRI) had no significant effect on chronic tension-type headache 4
- Amitriptyline was significantly more effective than citalopram 4
- The analgesic effect of amitriptyline is NOT primarily due to serotonin reuptake inhibition 7
The mechanism of amitriptyline's effectiveness appears related to norepinephrine reuptake inhibition, NMDA receptor antagonism, and reduction of central sensitization in myofascial tissues 7, 8—mechanisms that SSRIs lack.
Clinical Algorithm
- Episodic tension-type headache (<15 days/month): Use ibuprofen or acetaminophen as needed
- Chronic tension-type headache (≥15 days/month): Initiate amitriptyline 10 mg nightly, titrate to 30-75 mg over 4-8 weeks
- If patient is already on an SSRI: Either discontinue the SSRI (with appropriate taper) before starting amitriptyline, OR monitor closely for toxicity and use lower amitriptyline doses with plasma level monitoring 1
- Never use amitriptyline within 14 days of MAOI use (absolute contraindication) 1
Common Pitfall to Avoid
Do not assume that because amitriptyline affects serotonin, it can substitute for or be safely combined with SSRIs. The evidence clearly shows these are different drug classes with different efficacy profiles and dangerous interactions when combined 1, 6, 7.